By G HossainPosted on June 4, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs J&J has a multi-year head start, but Gilead believes it can win market share by delivering a drug with better safety and at least as good efficacy. Gilead Gears Up To Challenge J&J in $20B Multiple Myeloma CAR-T Market Post navigation Pharma Tuck-In Deals Grow After a Mediocre First Quarter for Small BiotechsM&A Ticks Up, ASCO Excites and Vaccines Cause More Drama